Dermatology Patients on Corticosteroids May Not Receive Osteoporosis Screenings; Plus FDA Approves ZTLido

In a comparative clinical adhesion study in healthy subjects (N=44), ZTlido demonstrated superior adhesion (P<0.0001) to Lidoderm at 3 hours that improved over the 12-hour administration period.

In a separate clinical study, ZTlido demonstrated strong adhesive properties even during moderate exercise. Mild skin reactions are common with transdermal systems; reactions usually spontaneously resolve within a few minutes to hours. Allergic and anaphylactoid reactions associated with lidocaine rarely occurred.

Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

References

1. Mowad C Cohen SF, Fussell NF, et al. Referral patterns to an osteoporosis clinic for dermatology patients undergoing prolonged corticosteroid therapy. J Am Acad Dermatol. 2018 Mar;78(3):591–592. doi: 10.1016/j.jaad.2017.01.058.
2. Sorrento Therapeutics Inc. News release: ZTlido uses novel technology demonstrating 12-hour wear for efficient lidocaine delivery, even during exercise. 2018 Feb 28.